Principe du test
Vitamin B9 ELISA Kit (A2068) employs the competitive enzyme immunoassay technique for the quantitative measurement of Vitamin B9 in serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. The 96-well microtiter plate has been pre-coated with Vitamin B9 antigen. During the incubation, Vitamin B9 present in the samples or standards competes with the fixed amount of immobilized Vitamin B9 for binding sites on the Biotinylated Anti-Vitamin B9 Antibody. The more Vitamin B9 present in a sample or standard, the less Biotinylated Anti-Vitamin B9 Antibody that binds to the plate. Following incubation, unbound Biotinylated Anti-Vitamin B9 Antibody is removed by washing, and an HRP-Avidin conjugate is added to the wells and the microtiter plate is incubated. Following incubation and washing, TMB substrate solution is then used to visualize the HRP enzymatic reaction by catalysis to produce a blue-coloured product that changes to yellow after addition of acidic stop solution. The density of yellow is inversely proportional to the amount of Vitamin B9 present in each sample or standard. The concentration of Vitamin B9 can then be calculated by reading the O.D. absorbance at 450nm in a microplate reader and referring to the standard curve.